North America Swine Vaccines Market Size & Outlook
North America swine vaccines market, 2018-2030 (US$M)
Related Markets
North America swine vaccines market highlights
- The North America swine vaccines market generated a revenue of USD 207.1 million in 2023.
- The market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
- In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
- Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 207.1 million |
| Market revenue in 2030 | USD 288.1 million |
| Growth rate | 4.8% (CAGR from 2023 to 2030) |
| Largest segment | Inactivated (killed) |
| Fastest growing segment | Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Key market players worldwide | Merck & Co Inc, CEVA Inc, Zoetis, Boehringer Ingelheim, Elanco Animal Health Inc, Indian Immunologicals, Biogenesis Bago, Phibro Animal Health Corp Class A, Virbac SA |
Other key industry trends
- In terms of revenue, North America region accounted for 12.5% of the global swine vaccines market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,145.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Swine Vaccines Market Scope
Swine Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America swine vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to swine vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 39.74% in 2023. Horizon Databook has segmented the North America swine vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines (e.g. recombinant, dna, subunit, or toxoids) covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of well-established veterinary healthcare infrastructure, highly structured agricultural systems, growing demand for animal protein, and rising farm owner investment in animal health are among factors contributing to the market growth in this region.
Countries, such as Canada and the U.S., have established and well-defined healthcare systems with a high concentration of key market players for the development of vaccines. For instance, in March 2022, Boehringer Ingelheim introduced the Repro Cyc Parvo FLEX swine parvovirus vaccine, which protects healthy sows and gilts aged 6 months and older from reproductive failure caused by porcine parvovirus.
For instance, in April 2022, scientists from the United States Department of Agriculture's Agricultural Research Service stated that a vaccine applicant for African swine fever passed an essential safety test necessary for regulatory acceptance, bringing the vaccine one step closer to commercial availability.
Reasons to subscribe to North America swine vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America swine vaccines market databook
-
Our clientele includes a mix of swine vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America swine vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into North America swine vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America swine vaccines market size, by country, 2018-2030 (US$M)
North America Swine Vaccines Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
